Intraocular Melanoma Completed Phase 1 Trials for Ipilimumab (DB06186)

Also known as: Intraocular melanoma NOS

IndicationStatusPhase
DBCOND0028574 (Intraocular Melanoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00025181Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During SurgeryTreatment